#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liver abscess Diffuse large B-cell lymphoma Nephropathy Haemolytic uraemic syndrome Conjunctivitis allergic Hyperphagia Non-renal cell carcinoma of kidney Liposarcoma recurrent Intracranial calcification VEXAS syndrome Cortical dysplasia Kawasaki's disease Atopic keratoconjunctivitis Palmar-plantar erythrodysaesthesia syndrome Rosai-Dorfman syndrome More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Basic Information Glycogen storage disease type II – Trials in Disease Castleman’s disease – Trials in Disease Prolymphocytic leukaemia Mucopolysaccharidosis I – Treatment Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Propionic acidaemia – Trials in Disease Brain stem glioma Splenic marginal zone lymphoma – Basic Information Congenital hypotransferrinaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cimetidine Sotatercept Betula Verrucosa (108) Ginisortamab Indometacin Piracetam GT-002 Bimekizumab Citalopram Hyoscine Butylbromide Feladilimab Dordaviprone Ucp2 Heterodimeric Interleukin-15 Etoposide Phosphate Efpegerglucagon Bms-986340 Pregabalin Budigalimab Rasburicase More therapies…

    Learn about Your Condition

    Benign neoplasm of ureter Pelizaeus-Merzbacher disease Pyoderma gangrenosum Myelodysplastic syndrome Systemic mastocytosis Colonoscopy Mucopolysaccharidosis I Haemoptysis Hypertrophic scar Inflammation Cervix carcinoma recurrent Obstructive airways disorder Trisomy 21 Acquired haemophilia Paraesthesia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on Early Treatment of Plaque Psoriasis with Bimekizumab and Clobetasol Propionate for Patients with Chronic Inflammation

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Clobetasol Propionate
    • Bimekizumab
    France

  • Study on the Safety of TOP-N53 for Treating Digital Ulcers in Systemic Sclerosis Patients

    Recruiting

    2 1 1
    Investigated Drugs:
    • 2-[1-(3-{6-[(1E)-(Hydroxyimino)Methyl]-5-Methyl-4-Oxo-7-Propyl-3H,4H-Pyrrolo[2,1-F][1,2,4]Triazin-2-Yl}-4-Propoxybenzenesulfonyl)Piperidin-4-Yl]Ethyl Nitrate
    • Sildenafil Citrate
    France

  • Study on Cemiplimab for Patients with High-Risk Stage III/IV Cutaneous Squamous Cell Carcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of skin
    Investigated Drugs:
    • Cemiplimab
    Italy

  • Study on the Effects of Belimumab for Patients with Systemic Lupus Erythematosus (SLE)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Belimumab
    The Netherlands

  • Study on the Effectiveness of EHSG-KF Skin Graft for Patients with Deep Partial and Full-Thickness Burns

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bilayer Engineered Collagen Hydrogel-Based Skin Graft Composed Of Autologous Keratinocytes And Fibroblasts
    Belgium France Germany Italy The Netherlands Poland +2

  • Study on the Effect of Prasterone on Genitourinary Syndrome in Postmenopausal Women with a History of Breast Cancer or Undergoing Anti-Hormonal Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Genitourinary syndrome of menopause
    • Breast cancer
    Investigated Drugs:
    • Prasterone
    Italy
Previous Page
1 … 9 10 11 12 13 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!